In agreement, it has been observed in in vitro studies with RA synoviocytes that the stimulation of these cells with proinflammatory mediators such as TNF-α or IL-1β increases the expression of Bcl-2 and, therefore, protects them from cell death in an inflammatory environment. The gene discussed is BCL2; the disease is rheumatoid arthritis.